TrialAnnals of the rheumatic diseases2020

Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study.

Paul Emery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.